Aspen Aerogels (NYSE:ASPN) Stock Price Down 11% – Here’s What Happened

Aspen Aerogels, Inc. (NYSE:ASPN)’s stock price was down 11% on Friday . The company traded as low as $5.67 and last traded at $6.1350. 672,679 shares were traded during trading, a decline of 58% from the average session volume of 1,592,493 shares. The stock had previously closed at $6.89.

Key Headlines Impacting Aspen Aerogels

Here are the key news stories impacting Aspen Aerogels this week:

• Positive Sentiment: Second-quarter revenue was $49.85 million, substantially above the analyst consensus of $42.42 million. Adjusted for expectations, the company’s loss of $0.22 per share was also slightly better than the projected $0.23 loss. Aspen Aerogels earnings results
• Positive Sentiment: Thermal Barrier revenue reached $29.5 million, an 81% sequential increase, highlighting continued momentum in the company’s electric-vehicle and battery-materials business. Aspen also raised its 2026 European Thermal Barrier revenue outlook to $20 million-$30 million. Aspen Aerogels second-quarter results
• Positive Sentiment: Third-quarter guidance was ahead of consensus: revenue of $65 million-$80 million versus an expected $56.6 million, EPS of negative $0.11 to negative $0.07 versus an expected negative $0.13, and adjusted EBITDA of $7 million-$15 million. The company also received a PyroThin award from Jaguar Land Rover for two next-generation vehicle architectures. Aspen Aerogels Q2 2026 earnings presentation
• Neutral Sentiment: News coverage also focused on Aspen Aerogels’ Russell 1000-related status, which may improve visibility and potentially support institutional interest, but it does not immediately change the company’s operating results. Aspen Aerogels Russell 1000 news
• Negative Sentiment: Aspen remains unprofitable: the quarterly loss widened from $0.04 per share a year earlier to $0.22, while its negative net margin and negative return on equity underscore ongoing profitability concerns. Investors may be questioning how quickly revenue growth will translate into sustainable earnings. Aspen Aerogels Q2 loss and revenue report

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ASPN shares. B. Riley Financial reissued a “buy” rating on shares of Aspen Aerogels in a report on Friday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Roth Capital reissued a “buy” rating and issued a $7.75 price target on shares of Aspen Aerogels in a report on Friday. Finally, Barclays boosted their price objective on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research report on Monday, May 11th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $5.69.

Aspen Aerogels Stock Down 8.8%

The firm’s 50 day simple moving average is $5.51 and its 200 day simple moving average is $4.41. The company has a market cap of $520.90 million, a price-to-earnings ratio of -4.64 and a beta of 2.99. The company has a quick ratio of 2.54, a current ratio of 2.89 and a debt-to-equity ratio of 0.32.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The business had revenue of $37.88 million for the quarter, compared to the consensus estimate of $36.58 million. Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The business’s quarterly revenue was down 51.8% on a year-over-year basis. During the same period last year, the firm posted ($0.06) EPS. Sell-side analysts anticipate that Aspen Aerogels, Inc. will post -0.8 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several large investors have recently added to or reduced their stakes in ASPN. Royal Bank of Canada boosted its position in Aspen Aerogels by 84.7% during the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock worth $360,000 after acquiring an additional 25,880 shares during the period. AQR Capital Management LLC acquired a new position in shares of Aspen Aerogels during the first quarter valued at $960,000. Integrated Wealth Concepts LLC bought a new stake in shares of Aspen Aerogels during the first quarter valued at about $84,000. Goldman Sachs Group Inc. raised its stake in shares of Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after purchasing an additional 602,586 shares in the last quarter. Finally, Caxton Associates LLP acquired a new stake in Aspen Aerogels in the first quarter worth about $307,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.